Prevalence of low back pain is between 31% - 47 % in the general population. 80 % of patients with acute low back pain who receive treatment return to work within one month, but that 7 % can develop chronic low back pain. On the other hand, more than 60% of people with acute low back pain who do not receive treatment develop chronic low back pain or have reoccurrence. Therefore, proper and early treatment appears to avoid the transition into chronic low back pain.
A 2013 clinical trial published in Spine compared Spinal Manipulation Therapy (SMT) to the nonsteroidal anti-inflammatory Diclofenac (NSAID) for acute, non specific low back pain. A total of 101 patients with acute low back pain (LBP) for less than 48 hours were recruited. The subjects were randomized into three groups:
Group 1: Spinal manipulation, placebo diclofenac
Group 2: Sham manipulation, diclofenac
Group 3: Sham manipulation and placebo diclofenac
Outcomes were measured by a blinded investigator that included self rated physical disability, function, time off work, and rescue medication during the 12 week study. The double placebo group 3 had a high number of dropouts due to unsustainable pain, so that group was closed before the end of the trial. Comparing the two active interventions, the manipulation group was significantly superior then the diclofenac group, with no adverse effects recorded. Subjects reported a better quality of life after spinal manipulation compared to diclofenac and patients in the NSAID group took almost three times as much rescue medication compared to the spinal manipulation group.
Citation: Spinal High Velocity Low Amplitude Manipulation in Acute Nonspecific Low Back Pain: A Double Blinded Randomized Controlled Trial in Comparision with Diclofenac and Placebo.
Von Heymann, et al. Spine 38(7)540-548, April, 2013